DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 55 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,277,000 | +18.7% | 245,582 | +25.1% | 0.00% | 0.0% |
Q4 2021 | $1,918,000 | -28.1% | 196,293 | +150.1% | 0.00% | -50.0% |
Q3 2021 | $2,667,000 | +48.5% | 78,486 | +60.0% | 0.00% | +100.0% |
Q2 2021 | $1,796,000 | -0.9% | 49,059 | +21.3% | 0.00% | 0.0% |
Q1 2021 | $1,813,000 | -14.1% | 40,434 | +9.3% | 0.00% | 0.0% |
Q4 2020 | $2,111,000 | +72.2% | 36,990 | +54.8% | 0.00% | 0.0% |
Q3 2020 | $1,226,000 | -29.3% | 23,893 | -17.7% | 0.00% | 0.0% |
Q2 2020 | $1,734,000 | +34.4% | 29,029 | -7.4% | 0.00% | 0.0% |
Q1 2020 | $1,290,000 | -46.0% | 31,337 | -18.4% | 0.00% | -50.0% |
Q4 2019 | $2,390,000 | +166.1% | 38,401 | +45.1% | 0.00% | +100.0% |
Q3 2019 | $898,000 | +51.7% | 26,473 | +0.9% | 0.00% | – |
Q2 2019 | $592,000 | +9.4% | 26,236 | +12.5% | 0.00% | – |
Q1 2019 | $541,000 | +21.0% | 23,314 | +9.4% | 0.00% | – |
Q4 2018 | $447,000 | -73.4% | 21,319 | -50.9% | 0.00% | -100.0% |
Q3 2018 | $1,680,000 | +24.9% | 43,379 | +27.0% | 0.00% | 0.0% |
Q2 2018 | $1,345,000 | +231.3% | 34,170 | +91.0% | 0.00% | – |
Q4 2017 | $406,000 | – | 17,894 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |